Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

RESTORE · User-centred smart nanobiomaterial-based 3D matrices for chondral repair

H2020Status: CLOSED1 January 201931 August 2022EU funding €5,539,736Call H2020-NMBP-TR-IND-2018-2020

The RESTORE project aims at developing an effective approach to manage the specific unmet clinical needs to treat knee chondral lesions. RESTORE, built upon the consortium’s proofs-of-concept and discussions between orthopaedic surgeons, tissue engineers, material scientists, cell biologists and SMEs, will realize a new generation of smart nanoenabled 3D matrices able to fit into complex lesion geometry, modulate undesirable biological events, and remotely control, stimulate and monitor cartilage repair. To create smart and functional 3D matrices, RESTORE will develop (i) nanobiomaterial-based nanocarriers to modulate inflammatory, cartilage extracellular matrix degradation and infection threats, (ii) stimuli-responsive nanobiomaterials tuned via external physical stimulus using radiofrequency and electromagnetic fields, and (iii) non-invasive wearable and wireless device for remote stimulus and regeneration monitoring. The nanobiomaterials will be integrated into cutting-edge 3D matrices that meet the needs of severe and mild chondral lesions: 1) the COPLA Scaffold commercialised since 2017 for animal health use and 2) 3D cartilage microtissues engineered via 3D bioprinting of iPS cells in a nanocellulose and alginate bioink. The technology development in RESTORE will reach TRL5 and enable substantial clinical advances in regenerative medicine. Untreated or not-correctly treated chondral lesions are likely to progress towards osteoarthritis (OA), which affects 242 million people globally (costs/patient/year: 10,452€). RESTORE will address the shortfalls of current therapeutic solutions while aiming to reduce the overall burden of OA. RESTORE’s outcomes hold high exploitation and commercial potential to boost the competitiveness of European companies, striving to diminish or delay the onset of OA, reducing hospitalization, number of surgeon interventions and time off work, thus leading to more cost-efficient health care and promote wellbeing and active ageing.

Consortium · 12 organisations

coordinator

INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA

PT · €933,243

participant

OULUN YLIOPISTO

FI · €918,803

participant

UNIVERSITAET ULM

DE · €409,313

participant

3DTECH OY

FI · €194,089

participant

BRINTER OY

FI · €205,286

participant

SINTEF AS

NO · €699,705

participant

ASKEL HEALTHCARE OY

FI · €303,750

participant

UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO

IT · €449,938

participant

VASTRA GOTALANDSREGIONEN

SE · €553,050

participant

FUNDACION CIDETEC

ES · €554,375

participant

HASKOLINN I REYKJAVIK EHF

IS · €318,185

participant

GOETEBORGS UNIVERSITET

SE

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.